TABLE 1.

Patient characteristics

Pt No.	Age (yrs), Sex	Flandedness	Age of Onset	Epilepsy Type	Ictal Onset Zone	MRI Findings	AEDs	Comorbidities; SSRI Tx	SUDEP Risk	No. of Clinical Sz	No. of Sz w/Interpretable Resp Signal	No. of Sz w/Apnea
1	36, M	Rt	2	Rt TLE	Mesial HC	MTS, perinatal ischemia	Oxcarbazepine, topiramate, pregabalin, clonazepam	Anxiety & ADHD; N	High	5	1	1
2	48, M	Rt	37	Rt TLE	Pst/mesial HC	None	Levetiracetam, lamotrigine, oxcarbazepine	OSA & depression; Y	Low	12	4	3
3	35, F	Rt	32	Rt TLE	Mesial temp	FCD*	Levetiracetam, clonazepam	None; N	Low	4	1	1
4	28, F	Rt	1	Lt TLE	Ant basal temp	MTS & FCD*	Lamotrigine, topiramate, levetiracetam	None; N	High	4	2	2
5	59, F	Rt	12	Lt TLE	Mesial temp	None	Valproic acid, lacosamide, primidone	None; N	High	9	9	9
6	34, M	Rt	24	Lt TLE	Pst basal temp	Likely FCD	Levetiracetam, carbamazepine	None; N	Low	5	2	0
7	26, F	Rt	9	Lt TLE	Ant HC	MTS	Levetiracetam, lamotrigine, carbamazepine, zonisamide	Depression; Y	High	12	1	0
8	25, F	Rt	22	Lt TLE	Ant basal temp	FCD*	Levetiracetam, lamotrigine	Anxiety; Y	Low	4	2	1

ADHD = attention deficit hyperactivity disorder; AED = anti-epileptic drug; Ant = anterior; FCD = focal cortical dysplasia; HC = hippocampus; MTS = mesial temporal sclerosis; N = no; OSA = obstructive sleep apnea; pst = posterior; pt = patient; resp = respiratory; SSRI = selective serotonin reuptake inhibitor; Sz = seizure(s); temp = temporal; Tx = therapy; Y = yes.

^*Confirmed on pathological examination.